» Articles » PMID: 32728990

Early Detection of Ventricular Dysfunction by Tissue Doppler Echocardiography Related to Cardiac Iron Overload in Patients with Thalassemia

Overview
Publisher Springer
Specialty Radiology
Date 2020 Jul 31
PMID 32728990
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac T2* MRI is used as a gold standard for cardiac iron quantification in patients with transfusion-dependent thalassemia (TDT). We hypothesized that left ventricular (LV) diastolic dysfunction would reflect the severity of iron overload and can serve as an early detection of cardiac iron deposits. A study was conducted on all patients with TDT. Hemoglobin, serum ferritin and non-transferrin bound iron, together with a complete echocardiography and cardiac T2* MRI, were performed on all patients. Seventy-seven patients with TDT were enrolled (median age 14 years). In the patient group with a mean serum ferritin of > 2500 ng/mL during the past 12 months, there were more patients with severe cardiac iron deposits than in the group with a mean serum ferritin of ≤ 2500 ng/mL. Diastolic dysfunction was absent in all patients with a serum ferritin of < 1000 ng/mL. All patients with cardiac T2* ≤ 20 ms had grade III LV diastolic dysfunction. However, twenty-one percent of patients with cardiac T2* > 20 ms had LV diastolic dysfunction. The differences observed in pulmonary vein atrial reversal duration and mitral A-wave (PVAR-MVA) duration ≥ - 1 ms and an E/E' ratio ≥ 11 were proven to be the associated factors with the cardiac T2* ≤ 20 ms. Increased PVAR-MVA duration and increased E/E' ratio reliably reflected a severe iron overload, according to a cardiac T2* in patients with TDT. LV diastolic dysfunction can occur prior to severe cardiac iron deposition. Tissue Doppler echocardiography has the potential for the early detection of cardiac involvement in patients with TDT .

Citing Articles

Correlation study between magnetic resonance imaging-quantitated cardiac iron deposition and left ventricular function in patients with β-thalassemia major in China.

Peng S, Xu F, Yang G, Zhang Y, Tang Q, Liu R Sci Prog. 2025; 108(1):368504251318196.

PMID: 39887257 PMC: 11786262. DOI: 10.1177/00368504251318196.


Safety of erythrocyte transfusion over a short period in pediatric patients assessed using cardiac deformation imaging.

Algiraigri A, Alkhushi N, Elnakeeb M, Abdelsalam M, Badawi M, Abdelmohsen G Eur J Pediatr. 2024; 184(1):84.

PMID: 39672939 DOI: 10.1007/s00431-024-05912-w.


Diagnostic Modalities in Detecting Cardiovascular Complications of Thalassemia.

Fianza P, Pramono A, Ghozali M, Sihite T, Setiabudi D, Syamsunarno M Rev Cardiovasc Med. 2024; 23(8):267.

PMID: 39076648 PMC: 11266957. DOI: 10.31083/j.rcm2308267.


Ferroptosis: The Potential Target in Heart Failure with Preserved Ejection Fraction.

Li Q, Zhao Z, Zhou X, Yan Y, Shi L, Chen J Cells. 2022; 11(18).

PMID: 36139417 PMC: 9496758. DOI: 10.3390/cells11182842.


T2-weighted cardiovascular magnetic resonance and echocardiographic arterial elasticity criteria for monitoring cardiac siderosis in patients with beta-thalassemia major.

Zavar R, Hendimarjan M, Behjati M, Yazdani D J Res Med Sci. 2022; 27:44.

PMID: 35968210 PMC: 9374138. DOI: 10.4103/jrms.jrms_705_21.


References
1.
Origa R . β-Thalassemia. Genet Med. 2016; 19(6):609-619. DOI: 10.1038/gim.2016.173. View

2.
Olivieri N, Nathan D, MacMillan J, Wayne A, Liu P, McGee A . Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994; 331(9):574-8. DOI: 10.1056/NEJM199409013310903. View

3.
Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini M, Del Vecchio G . Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89(10):1187-93. View

4.
Poggiali E, Cassinerio E, Zanaboni L, Cappellini M . An update on iron chelation therapy. Blood Transfus. 2012; 10(4):411-22. PMC: 3496216. DOI: 10.2450/2012.0008-12. View

5.
Lara Fernandes J . Iron chelation therapy in the management of transfusion-related cardiac iron overload. Transfusion. 2012; 52(10):2256-68. DOI: 10.1111/j.1537-2995.2012.03580.x. View